Evidence map›Paper›PMID 32806657›Full record

ReviewMicroorganisms2020

COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions.

Carlo Contini, Elisabetta Caselli, Fernanda Martini, Martina Maritati, Elena Torreggiani, Silva Seraceni, Fortunato Vesce, Paolo Perri, Leonzio Rizzo, Mauro Tognon

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Role of the Microbiome in the Pathogenesis of COVID-19.Frontiers in cellular and infection microbiology · 2022
    Review
  12. Article
  13. Review
  14. Impact of COVID-19 prevention measures onExperimental and therapeutic medicine · 2021
    Article
  15. Zoonotic and anthropozoonotic potential of COVID-19 and its implications for public health.Environmental science and pollution research international · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Carlo ContiniInfectious Diseases and Dermatology Section, Pathology, Oncology and Experimental Biology Section, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-8809-6470
Elisabetta CaselliDepartment of Chemical and Pharmaceutical Sciences, Microbiology Section, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-6048-9141
Fernanda MartiniInfectious Diseases and Dermatology Section, Pathology, Oncology and Experimental Biology Section, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy.
Martina MaritatiDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-9938-8492
Elena TorreggianiInfectious Diseases and Dermatology Section, Pathology, Oncology and Experimental Biology Section, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-7874-2002
Silva SeraceniRDI, Rete Diagnostica Italiana s.r.l, Lifebrain Group, Limena, 35010 Padova, Italy.
Fortunato VesceDepartment of Morphology, Surgery and Experimental Medicine, Obstetrics and Gynecology Section, University of Ferrara, 44124 Ferrara, Italy.
Paolo PerriDepartment of Biomedical Sciences and Surgical Specialties; Ophthalmology Section, University of Ferrara, 44124 Ferrara, Italy.
Leonzio RizzoDepartment of Economy and Management; University of Ferrara, 44124 Ferrara, Italy.
Mauro TognonInfectious Diseases and Dermatology Section, Pathology, Oncology and Experimental Biology Section, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Until less than two decades ago, all known human coronaviruses (CoV) caused diseases so mild that they did not stimulate further advanced CoV research. In 2002 and following years, the scenario changed dramatically with the advent of the new more pathogenic CoVs, including Severe Acute Respiratory Syndome (SARS-CoV-1), Middle Eastern respiratory syndrome (MERS)-CoV, and the new zoonotic SARS-CoV-2, likely originated from bat species and responsible for the present coronavirus disease (COVID-19), which to date has caused 15,581,007 confirmed cases and 635,173 deaths in 208 countries, including Italy. SARS-CoV-2 transmission is mainly airborne via droplets generated by symptomatic patients, and possibly asymptomatic individuals during incubation of the disease, although for the latter, there are no certain data yet. However, research on asymptomatic viral infection is currently ongoing worldwide to elucidate the real prevalence and mortality of the disease. From a clinical point of view, COVID-19 would be defined as "COVID Planet " because it presents as a multifaceted disease, due to the large number of organs and tissues infected by the virus. Overall, based on the available published data, 80.9% of patients infected by SARS-CoV-2 develop a mild disease/infection, 13.8% severe pneumonia, 4.7% respiratory failure, septic shock, or multi-organ failure, and 3% of these cases are fatal, but mortality parameter is highly variable in different countries. Clinically, SARS-CoV-2 causes severe primary interstitial viral pneumonia and a "cytokine storm syndrome", characterized by a severe and fatal uncontrolled systemic inflammatory response triggered by the activation of interleukin 6 (IL-6) with development of endothelitis and generalized thrombosis that can lead to organ failure and death. Risk factors include advanced age and comorbidities including hypertension, diabetes, and cardiovascular disease. Virus entry occurs via binding the angiotensin-converting enzyme 2 (ACE2) receptor present in almost all tissues and organs through the Spike (S) protein. Currently, SARS-CoV-2 infection is prevented by the use of masks, social distancing, and improved hand hygiene measures. This review summarizes the current knowledge on the main biological and clinical features of the SARS-CoV-2 pandemic, also focusing on the principal measures taken in some Italian regions to face the emergency and on the most important treatments used to manage the COVID-19 pandemic.

Indexed as

COVID-19COVID-19 planetcytokine storm syndromeendothelitishyperinflammationSARS-CoV-2thromboembolism

Identifiers

PMID32806657
PMCPMC7464234
OpenAlexW3048368187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.